1. Home
  2. DUOT vs SABS Comparison

DUOT vs SABS Comparison

Compare DUOT & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Duos Technologies Group Inc.

DUOT

Duos Technologies Group Inc.

HOLD

Current Price

$11.23

Market Cap

210.3M

Sector

Technology

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.98

Market Cap

187.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DUOT
SABS
Founded
1990
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
210.3M
187.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DUOT
SABS
Price
$11.23
$3.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$14.00
$9.80
AVG Volume (30 Days)
237.5K
352.6K
Earning Date
11-12-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$19,026,308.00
$114,698.00
Revenue This Year
$286.66
N/A
Revenue Next Year
$44.93
N/A
P/E Ratio
N/A
N/A
Revenue Growth
159.00
N/A
52 Week Low
$3.84
$1.00
52 Week High
$12.17
$6.60

Technical Indicators

Market Signals
Indicator
DUOT
SABS
Relative Strength Index (RSI) 56.30 56.72
Support Level $10.16 $3.93
Resistance Level $11.24 $4.21
Average True Range (ATR) 0.68 0.26
MACD 0.04 0.01
Stochastic Oscillator 82.61 71.14

Price Performance

Historical Comparison
DUOT
SABS

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: